Bicocca Open Archive

Logo unimib boa
ALBERTI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.733
AS - Asia 19.240
EU - Europa 11.125
SA - Sud America 2.043
AF - Africa 366
OC - Oceania 59
Continente sconosciuto - Info sul continente non disponibili 17
Totale 56.583
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.342
VN - Vietnam 6.065
SG - Singapore 5.464
CN - Cina 3.175
IT - Italia 2.828
HK - Hong Kong 1.991
RU - Federazione Russa 1.639
DE - Germania 1.571
BR - Brasile 1.527
CA - Canada 1.186
SE - Svezia 1.110
IE - Irlanda 892
GB - Regno Unito 693
IN - India 517
FR - Francia 483
KR - Corea 400
UA - Ucraina 398
FI - Finlandia 314
BD - Bangladesh 277
TR - Turchia 223
AR - Argentina 198
JP - Giappone 191
ID - Indonesia 184
ES - Italia 166
AT - Austria 161
NL - Olanda 160
IQ - Iraq 141
LT - Lituania 136
DK - Danimarca 126
MX - Messico 116
ZA - Sudafrica 114
PK - Pakistan 98
CH - Svizzera 93
PL - Polonia 87
SA - Arabia Saudita 82
EC - Ecuador 77
PH - Filippine 66
CO - Colombia 65
BE - Belgio 63
VE - Venezuela 60
AU - Australia 54
MA - Marocco 48
UZ - Uzbekistan 44
EG - Egitto 38
MY - Malesia 37
TW - Taiwan 35
PY - Paraguay 33
ET - Etiopia 31
GR - Grecia 31
CL - Cile 29
TN - Tunisia 28
IL - Israele 26
RO - Romania 25
AE - Emirati Arabi Uniti 24
JO - Giordania 24
TH - Thailandia 24
PE - Perù 23
KZ - Kazakistan 22
PT - Portogallo 22
DZ - Algeria 21
KE - Kenya 20
IR - Iran 19
AZ - Azerbaigian 18
CR - Costa Rica 16
CZ - Repubblica Ceca 16
AL - Albania 15
BO - Bolivia 15
UY - Uruguay 15
BG - Bulgaria 14
JM - Giamaica 14
NP - Nepal 14
OM - Oman 14
EU - Europa 13
HR - Croazia 13
HN - Honduras 12
HU - Ungheria 12
AO - Angola 11
BH - Bahrain 11
PA - Panama 11
GT - Guatemala 10
LV - Lettonia 10
LY - Libia 10
NG - Nigeria 10
PS - Palestinian Territory 9
LB - Libano 8
NO - Norvegia 8
SC - Seychelles 8
SI - Slovenia 8
KG - Kirghizistan 7
MD - Moldavia 7
NI - Nicaragua 7
TT - Trinidad e Tobago 7
BN - Brunei Darussalam 5
CI - Costa d'Avorio 5
DO - Repubblica Dominicana 5
RS - Serbia 5
GE - Georgia 4
KW - Kuwait 4
LU - Lussemburgo 4
NZ - Nuova Zelanda 4
Totale 56.516
Salva come PNG Salva come JPEG
Città #
Singapore 3.177
Ann Arbor 3.160
Dallas 2.706
Hong Kong 1.934
Ho Chi Minh City 1.832
Ashburn 1.818
Hanoi 1.522
San Jose 1.388
Milan 930
Toronto 892
Dublin 865
Fairfield 860
Woodbridge 831
Wilmington 793
Frankfurt am Main 775
Chandler 718
Houston 583
New York 574
Los Angeles 521
Santa Clara 516
Dearborn 505
Chicago 404
Beijing 396
Hefei 393
Seattle 386
Jacksonville 370
Seoul 332
Princeton 330
The Dalles 298
Cambridge 293
Boardman 265
Council Bluffs 217
Nanjing 213
Lauterbourg 209
Da Nang 202
Haiphong 194
Munich 193
Buffalo 173
Helsinki 171
Shanghai 162
São Paulo 161
Moscow 151
Guangzhou 150
Ha Long 136
Vienna 123
Jakarta 119
Vilnius 115
Hải Dương 112
Orem 111
Biên Hòa 108
Quận Bình Thạnh 108
Tokyo 100
Lawrence 94
Rome 92
London 89
Ninh Bình 85
Chennai 84
Can Tho 83
Thái Nguyên 81
Columbus 80
Altamura 77
Vũng Tàu 76
Bắc Ninh 74
Montreal 73
Denver 69
Dong Ket 69
Zurich 64
Baghdad 63
Basingstoke 63
Warsaw 63
Nuremberg 61
Phoenix 61
Atlanta 60
Quận Một 60
Shenyang 58
Stockholm 58
Rio de Janeiro 57
Amsterdam 56
Lachine 55
Manchester 55
Nanchang 55
San Diego 55
Turin 54
Andover 52
Poplar 52
Bắc Giang 51
Hangzhou 51
Tianjin 51
Brooklyn 49
Changsha 49
Carate Brianza 45
Kent 45
Pune 44
Brussels 43
Johannesburg 43
Florence 42
Phủ Lý 42
Mexico City 41
Hebei 40
Jinan 39
Totale 36.498
Salva come PNG Salva come JPEG
Nome #
Oxaliplatin-induced Alteration of Sodium-Calcium Exchanger as a Pivotal Element Leading to Peripheral Neurotoxicity and Necroptosis 774
SODIUM-CALCIUM EXCHANGER PIVOTAL ROLE IN OXALIPLATIN-INDUCED PERIPHERAL NEUROTOXICITY, AXONAL DAMAGE AND NECROPTOSIS 635
High-Resolution MRI for Peripheral Nervous System Imaging: Volumetric Rendering in Rodent Models 612
Sodium-Calcium Exchanger 2 Role In An In Vitro Oxaliplatin-Induced Peripheral Neurotoxicity Model 594
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 580
Translational Approach to Oxaliplatin Induced Peripheral Neurotoxicity - Neurophysiology: the Link between Bed and Bench "side" 520
In vitro neurotoxicity testing: lessons from chemotherapy-induced peripheral neurotoxicity 515
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 509
A PILOT STUDY ON HEALTH-ECONOMICS BURDEN DUE TO CHEMOTHERAPY-INDUCED NEUROTOXICITY 488
Nelarabine-Induced Neurotoxicity: Reversible Damage not only on Peripheral Nerves 482
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 458
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 446
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 446
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes 444
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 428
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 425
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 420
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 413
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings 410
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 401
Neuropatie periferiche da chemioterapia 392
Toxic Medications in Charcot-Marie-Tooth Patients: A Systematic Review 391
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 390
Guillain-Barré syndrome related to COVID-19 infection 389
Ion Channel and Transporter Involvement in Chemotherapy-Induced Peripheral Neurotoxicity 387
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 384
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics 377
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 371
Investigation of Supraspinal Plasticity in a Rat Model of Painful Paclitaxel-induced Peripheral Neuropathy 361
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 360
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 354
3D Digital tools in human anatomy teaching from peer-to-peer tutoring to clinically oriented approaches: a single center experience. 354
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) 343
Oxaliplatin-induced Peripheral Neurotoxicity: role of ion channels/transporters in axonal damage. 336
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 333
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings 325
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 325
Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)—a white paper 323
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 320
3D Digital tools in neuro-anatomy teaching: from peer-to-peer tutoring to clinically oriented approaches 317
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 316
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 313
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 312
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 311
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin 309
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 306
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 306
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 304
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 304
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve 302
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 301
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 301
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 300
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 297
Neuropathic pain and chemotherapy-induced peripheral neurotoxicity: the issue 295
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 294
Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: A genome-wide study replication and meta-analysis 294
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 293
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 293
Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care—an international Delphi study 292
Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer 292
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 292
Guillain–Barré Syndrome Associated with COVID-19 288
Severe, reversible nelarabine-induced neuropathy and myelopathy 284
In vivo study of Carfilzomib-Induced Neuropathy 282
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 280
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 279
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 278
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 276
Histone deacetylases inhibitors: a new frontier for neuroprotection? 275
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 272
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 272
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients 271
Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools 271
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNoms study 270
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 270
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 265
A Longitudinal Study on Oxaliplatin Induced Peripheral Neuropathy – Incidence and Facts About the “Real Life” Population And Actual Dose 265
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 264
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 261
Neurophysiological examination of dorsal sural nerve 260
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin 257
Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data 256
Neurofilament light chain serum levels as a possible paclitaxel-induced peripheral neurotoxicity biomarker: pilot and feasibility study. 256
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 255
MITOCHONDRIAL DYSFUNCTION IS A FEATURE OF PACLITAXEL AND OXALIPLATIN-PROMOTED CHEMOTHERAPY-INDUCED PERIPHERAL NEUROTOXICITY 254
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 253
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 252
Incidence, characteristics, and associations of oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: Results of a prospective, multicenter, international study. 248
Chemotherapy-induced neuropathy 247
Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study 247
The significance of dorsal sural nerve recordings in early detecting oxaliplatin-induced peripheral neuropathy. 244
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 242
When progressive dysphagia could be related to an “old friend” – a case report 242
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 241
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients 239
Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: Results from a prospective multicenter study 237
Chapter 16. Impact of COVID-19 on pre-existing neurological diseases 237
Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial 234
Dorsal sural nerve conduction study in the assessment of oxaliplatin induced peripheral neuropathy 233
Totale 33.616
Salva come PNG Salva come JPEG
Categoria #
all - tutte 174.465
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.465
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021304 0 0 0 0 0 0 0 0 0 0 0 304
2021/20222.010 147 252 179 179 171 165 79 91 112 130 174 331
2022/20233.550 434 806 333 313 272 575 78 193 251 69 121 105
2023/20243.401 112 168 174 158 389 706 623 161 240 94 95 481
2024/20259.336 449 1.032 827 426 789 378 681 327 944 1.207 848 1.428
2025/202628.173 5.256 3.124 3.576 2.170 2.273 1.281 3.313 1.137 1.783 1.962 1.588 710
Totale 58.452